Advertisement The Upsher-Smith Galaxy portfolio of antiepileptic drugs now available - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

The Upsher-Smith Galaxy portfolio of antiepileptic drugs now available

Upsher-Smith Laboratories announced that it has launched the Upsher-Smith Galaxy, a new and growing suite of antiepileptic drugs (AEDs) that offers people with epilepsy consistent, affordable and accessible therapies.

The current Upsher-Smith Galaxy Portfolio includes seven frequently prescribed AEDs which represent more than one out of every three prescriptions written for seizure disorders.

The launch of the Upsher-Smith Galaxy demonstrates the company’s commitment to simplifying access to effective treatments and reducing healthcare costs. Plus, clinicians and patients can feel confident knowing that with the Upsher-Smith Galaxy AED portfolio therapies, they will receive consistent quality product with every refill.

"Upsher-Smith is known for providing much-needed medications made to exacting standards with proven consistency and reliability," said Mark Evenstad, President and Chief Executive Officer of Upsher-Smith.

"The Upsher-Smith Galaxy Portfolio offers clinicians and their patients affordable access day in and day out to a growing suite of frequently prescribed seizure medications with high quality therapy from refill to refill."

The Upsher-Smith Galaxy is available by mail order from Thrifty White Pharmacy.